<DOC>
	<DOCNO>NCT02242006</DOCNO>
	<brief_summary>Severe acute kidney injury ( AKI ) common complication critical illness affect almost half patient septic shock . Extracorporeal renal replacement therapy cornerstone management AKI patient . Options renal replacement therapy include continuous renal replacement ( CRRT ) therapy , intermittent dialysis ( IHD ) hybrid form two call sustain low efficiency dialysis ( SLED ) . Globally push switch traditional CRRT SLED . Although resource financial comparative benefit SLED almost literature describe dose antimicrobial ( drug matter ) . It appear drug clearance SLED may efficient CRRT efficient IHD make extrapolation body literature inappropriate SLED . The investigator propose conduct population pharmacokinetic study three commonly use antimicrobial critically ill patient receive SLED therapy ( piperacillin-tazobactam , meropenem vancomycin ) . Population pharmacokinetic modeling drug provide estimate source variability around pharmacokinetic parameter subsequently use Monte Carlo simulation determine appropriate dosing regimen achieve therapeutic target minimize risk toxicity .</brief_summary>
	<brief_title>Antimicrobial Pharmacokinetics Critically Ill Adults During Sustained Low Efficiency Dialysis ( SLED )</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Critically ill adults [ age ≥ 18 ] admit one two medical/surgical intensive care unit ( ICUs ) The Ottawa Hospital , require SLED receive meropenem , piperacillintazobactam vancomycin therapy dose . Patients participation via informed consent process deny . Critically ill patient hypermetabolic state due &gt; 25 % coverage body surface area burn , cystic fibrosis , spinal cord injury , bariatric patient ( define &gt; 150kg total body weight ) Patient pregnant per positive serum urine βHCG qualitative assay Patient closedsystem arterial central venous catheter ( minimize blood wastage ) Patients receive concomitant drug know interact metabolism clearance antimicrobial interest accord Micromedex 2.0 ( Truven Health Analytics Inc 2013 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>